Voglibose 0.2 mg Tablet is an oral anti-diabetic medicine widely prescribed for the management of type 2 diabetes mellitus, especially for controlling post-meal blood sugar levels. It belongs to the class of alpha-glucosidase inhibitors and is highly effective in managing postprandial hyperglycemia, which is one of the main causes of long-term diabetic complications.
Voglibose 0.2 mg Tablet is usually prescribed along with diet control, regular exercise, and other anti-diabetic medicines to maintain stable blood glucose levels. Regular monitoring of blood sugar is essential during treatment to ensure proper dose adjustment and maximum therapeutic benefit.
Composition
Each tablet contains: Voglibose – 0.2 mg Excipients q.s.
Working (Mechanism of Action)
Voglibose works by inhibiting intestinal alpha-glucosidase enzymes that break down complex carbohydrates into glucose. This delays the absorption of glucose from the intestine and prevents a sudden rise in blood sugar levels after meals, helping maintain better postprandial glucose control.
Uses / Indication
Voglibose 0.2 mg Tablet is used for:
Type 2 diabetes mellitus
Postprandial hyperglycemia
Prevention of macrovascular diabetic complications
Supporting overall blood glucose control
Medicinal Benefits
The medicinal benefits of using Voglibose 0.2 mg Tablet are:
Controls blood sugar spikes after meals
Improves overall glycemic control
Reduces the risk of long-term diabetic complications